Product Information
OXYCODONE HCL (IR) 30 MG TAB is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3569 per EA under NDC 31722091805. Its NADAC has been published 458 times since Dec 27, 2017.
FDA first approved this application on Aug 7, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722091805
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207418FDA Approved
8/7/2017
TE Code
AB
On Market Since
8/8/2017
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE HCL (IR) 30 MG TAB has been published 458 times since Dec 27, 2017, and over the history we have for it it has risen 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3569 per EA |
|---|---|
| All-time high | $0.3826 (Nov 13, 2024) |
| All-time low | $0.2151 (Mar 17, 2021) |
| 52-week high | $0.3617 |
| 52-week low | $0.3491 |
| Median price | $0.2574 |
| Average price | $0.2784 |
| Largest weekly change | +23.5% (Aug 21, 2024) |
| Weeks tracked | 458 |
| Tracking since | Dec 27, 2017 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE HCL (IR) 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE HCL (IR) 30 MG TAB, manufactured by Camber Pharmaceuticals Inc., is $0.3569 per EA (NDC 31722091805), effective Sep 30, 2026.
How has the price of OXYCODONE HCL (IR) 30 MG TAB changed over time?
Over the history we have for it, the NADAC for OXYCODONE HCL (IR) 30 MG TAB has risen 19.5%. It has been tracked across 458 weekly CMS publications since Dec 27, 2017.
What are the highest and lowest recorded NADAC prices for OXYCODONE HCL (IR) 30 MG TAB?
Since Dec 27, 2017, the NADAC for OXYCODONE HCL (IR) 30 MG TAB has ranged from a low of $0.2151 (Mar 17, 2021) to a high of $0.3826 (Nov 13, 2024), with a median of $0.2574 per EA.
Are there cheaper alternatives to OXYCODONE HCL (IR) 30 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE HCL (IR) 30 MG TAB, is $0.2529 per EA — about 29% below OXYCODONE HCL (IR) 30 MG TAB.
Who manufactures OXYCODONE HCL (IR) 30 MG TAB?
OXYCODONE HCL (IR) 30 MG TAB (NDC 31722091805) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.